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Abstract
Background: Recent data suggest that ribonucleotide reductase (RNR) exists not only as a
heterodimer R12R22 of R12 and R22 homodimers, but also as tetramers R14R24 and hexamers
R16R26. Recent data also suggest that ATP binds the R1 subunit at a previously undescribed
hexamerization site, in addition to its binding to previously described dimerization and
tetramerization sites. Thus, the current view is that R1 has four NDP substrate binding possibilities,
four dimerization site binding possibilities (dATP, ATP, dGTP, or dTTP), two tetramerization site
binding possibilities (dATP or ATP), and one hexamerization site binding possibility (ATP), in
addition to possibilities of unbound site states. This large number of internal R1 states implies an
even larger number of quaternary states. A mathematical model of RNR activity which explicitly
represents the states of R1 currently exists, but it is complicated in several ways: (1) it includes up
to six-fold nested sums; (2) it uses different mathematical structures under different substrate-
modulator conditions; and (3) it requires root solutions of high order polynomials to determine R1
proportions in mono-, di-, tetra- and hexamer states and thus RNR activity as a function of
modulator and total R1 concentrations.
Results: We present four (one for each NDP) rational polynomial models of RNR activity as a
function of substrate and reaction rate modifier concentrations. The new models avoid the
complications of the earlier model without compromising curve fits to recent data.
Conclusion: Compared to the earlier model of recent data, the new rational polynomial models
are simpler, adequately fitting, and likely better suited for biochemical network simulations.
Background
Ribonucleotide reductase (RNR) is a key component of de
novo deoxynucleotide (dNTP) metabolism and an impor-
tant target of cancer therapies [1]. This enzyme, which
reduces ribonucleoside diphosphates into corresponding
deoxyribonucleoside diphosphates, is exquisitely control-
led to properly balance dNTP fluxes in the face of chang-
ing scheduled (S phase) and unscheduled (DNA damage/
repair) dNTP synthesis demands [2].
Recent data [3-6] suggest that ribonucleotide reductase
(RNR) exists not only as a heterodimer R12R22 of R12 and
R22 homodimers [2], but also as a R14R24 tetramer and as
a R16R26 hexamer, where hexamer formation is driven by
ATP binding to a previously undescribed hexamerization
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site. Thus, in addition to its four substrate binding possi-
bilities in ADP, GDP, CDP, or UDP, and four dimeriza-
tion/specificity site binding possibilities in dATP, ATP,
dGTP, or dTTP, the current view (Figure 1) is that R1 has
two tetramerization/inhibitory site binding possibilities
in dATP or ATP, and one hexamerization/activation site
binding possibility in ATP, in addition to possibilities of
unbound site states. The resulting large number of possi-
ble R1 states implies an even larger number of quaternary
states, and this leads to a complicated mathematical
model of RNR activity [3-6]. This model, although useful
for explaining RNR activity data, is not useful for bio-
chemical network simulations because: a) it is unwieldy
(including up to six-fold nested sums), b) it uses different
mathematical structures under different substrate-modu-
lator conditions, and c) it requires root solutions of high
order polynomials to determine R1 proportions in mono-
, di-, tetra- and hexamer quaternary states, and thus RNR
activity, as a function of modulator and total R1 concen-
trations. Simpler mathematical reaction rate models of
RNR are needed if deoxynucleotide metabolism [7] is to
be represented using Systems Biology Markup Language
(SBML) [8-10], a standard which requires single algebraic
expression reaction rate laws in some applications
[11,12]. Based on recent data from Cooperman's group
[4-6], such expressions are provided here for RNR.
Results
Reaction activities are viewed here as weighted sums of
enzyme state specific activities multiplied by probabilities
of enzymes being in specific states. For example, a Michae-
lis-Menten reaction rate law is viewed as
where the probability that the enzyme is in a loaded/reac-
tive state (with activity kcat) is P(EA) and the probability
that the enzyme is in an empty/unreactive state (with no
activity) is P(E).
The RNR models presented here are based on the follow-
ing four enzyme state probability assumptions:
1. The probability that a particular R1 subunit is bound to
NDP is assumed to be
2. The probability that L ∈  {ATP, dATP, dTTP, dGTP} is
also bound to the dimerization/specificity site, condi-
tional on NDP binding, is assumed to be
where, if L = dTTP and NDP = GDP for example,
is the probability that dTTP is bound to the dimerization/
specificity site given that GDP is bound to the substrate
site; the probability of an empty dimerization/specificity
site is thus
3. The probability that the tetramerization site is either
empty, occupied by ATP, or occupied by dATP, is assumed
to be, respectively,
4. Finally, the probability that the hexamerization site is
occupied by ATP is assumed to be
Quaternary states of R1 Figure 1
Quaternary states of R1. Modulators of RNR activity listed in 
this figure bind R1 to create higher order quaternary states. 
Tetramers exist in an equilibrium between low activity states 
(see k4 in Table 1) and inactive states (kcat = 0). Adapted from 
Scheme 1 in [4,5].
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The subscripts a (activation), i (inactivation), and s (spe-
cificity) on the binding constants correspond to h (hexam-
erization),  t  (tetramerization), and d  (dimerization)
subscripts on P, respectively. That parameter values differ
depending upon which NDP substrate is bound to the
active site (see Table 1) is indicated by the conditional
probabilities.
Previous work [3-6] has shown that the dimer and hex-
amer states are active, that the tetramer state is slightly
active for ADP and GDP and is otherwise inactive, that
dimer state activity for CDP and UDP exists when ATP or
dATP is bound to the dimerization/specificity site, and
that an empty dimerization/specificity site still permits
the formation of some dimer with CDP reductase activity,
see Table 5 of [5]. Thus, based on the enzyme state prob-
abilities given above, for kcat implicitly defined through
we propose the following expressions:
ADP reduction
GDP reduction
CDP reduction
UDP reduction
In these equations, for ADP and GDP, the first factor is the
probability that the dimer site is occupied, and for CDP
and UDP, the first factor is the expectation of kcat condi-
tional on R1 being in a dimer state (i.e. having an empty
tetramerization site). In the ADP and GDP models, the
second factor is the conditional expectation of kcat given
that the dimerization site is occupied: the first term of this
second factor has in its numerator the statement that kcat
= k2 if the tetramerization site is empty, or kcat = k4 if it is
occupied by either dATP or ATP, and the second term
states that kcat = k6 if the hexamerization site is occupied by
ATP. For the CDP and UDP models, the first term of the
second factor is the probability of an empty tetrameriza-
tion site (the event that the corresponding first factor was
conditioned on), and the second term states that if the
ATP concentration is high enough that the hexameriza-
tion/second term dominates the tetramerization/first
term whilst the first factor approaches k2A, k6 is the overall
kcat. This rationale served as our model selection guide.
Importantly, the models fitted recent data [3-6] very well,
see Figure 2 and Table 1.
Table 1: Parameter estimates of the reductase models. Fits to data are as shown in Figure 2.
substrate KsdATP KsATP KsdTTP KsdGTP KidATP KiATP KaATP k2 k2dA k2A k2e k4 k6
ADP 2 200 2.4b 0.5 1.25 300 2000d 0.21 0.03 0.16
GDP 1 100 0.5 2 2 190 2400 0.28a 0.04 0.19
CDP 2 70 1.55b 2c 1.5 600 1400 0.25a 0.29a 0.08 0.32
UDP 1 100 0.7b 2c 0.5 200 800 0.26 0.26 0.26a
Binding constants in µM, rate constants in 1/s.
afixed values taken directly from table 5 of [5].
busing Eq. 10, these were adjusted to yield fluxes of 12.5, 12.5, 20 and 5 (uM/min) for ADP, GDP, CDP and UDP, respectively, under assumptions of 
E0 = 16 µM, ADP = 430 µM, GDP = 110 µM, CDP = 55 µM, UDP = 170 µM, KmADP = 12 µM, KmGDP = 4.9 µM, KmCDP = 2 µM, KmUDP = 6.4 µM, ATP 
= 1450 µM, dATP = 10.5 µM, dGTP = 7.3 µM, dTTP = 30 µM and the remaining parameter values in Table 1, see [7].
cno data, thus, these can be assumed to have any value between .5 and 2; a default value of 2 was carried down from GDP.
dno data, 2000 is based on the other rows.
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Discussion
In general, when an integrated system is engineered from
component subsystems, the behavior of the overall sys-
tem depends on component input-output specifications
more so than the details of component implementations.
By analogy, when enzymological data are applied to bio-
chemical network modeling, rather than the elucidation
of reaction mechanisms, it can be expected that the
Data from [4-6] and corresponding curve fits (Table 1) of the RNR activity models Figure 2
Data from [4-6] and corresponding curve fits (Table 1) of the RNR activity models. In these plots, from left to right, for ADP 
reduction dGTP was 2.1 uM or variable, for GDP reduction dTTP was 100 uM, 300 uM, variable, or 85 uM, and for pyrimidines 
specificity site binding concentrations were as shown. In all cases NDP and R2 were at saturating levels.
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reaction surfaces themselves (i.e. the enzyme's input-out-
put characteristics) determine network behavior more so
than the details of how such surfaces are represented.
Thus, for applications to systems biology, large confi-
dence intervals (CI) in the model parameter estimates of
Table 1 (not shown) are not a problem because only
goodness-of-fit (Fig. 2) really matters; this claim assumes
an operating range within the data range, since similarly
fitting models often veer apart when used in extrapola-
tions. If reaction mechanism inferences were instead
being sought, the large CI in the model parameter esti-
mates would have been a problem, e.g. the squared terms
in the model suggest cooperative binding, but this choice
provides only slightly better curve fits compared to linear
terms (not shown), so cooperative binding cannot be
inferred from this model.
In the RNR model presented here, the proportion of R1
units existing in monomer, dimer, tetramer, or hexamer
states, and thus the RNR activity per unit enzyme, depends
on site binding occupancies but does not depend on the
total R1 concentration. In the more complicated previous
model [3-6], higher total R1 concentrations favor higher
order quaternary states. The degree to which this is so is
illustrated by plots of predicted GDP reductase activity as
a function of ATP concentration at various R1 concentra-
tions (Figure 3). Consistent with the formation of higher
order quaternary R1 states, these plots contract to the left
as the total R1 concentrations increase from 1 µM to 100
µM. In future work, the model given here will be altered
to capture such trends without losing its simplicity; the
total R1 concentration will enter such a model not only as
a linear modulator of the reaction surface amplitude (i.e.
E0 in Eq. 10), but also as a modifier of reaction surface
shape parameters, e.g. KaATP will be replaced by a decreas-
ing function of R1.
Conclusion
We identified a rational polynomial model of RNR activ-
ity that has single algebraic expressions for each reductase
reaction rate law. The expressions provide reasonably
good fits (Fig. 2) to recent data [3-6]. Compared to previ-
ous reaction rate expressions for this data [3-6], the new
expressions are simpler and thus better suited for bio-
chemical network simulations, particularly those con-
strained to use enzyme reaction rate laws defined as single
algebraic expressions [11,12].
Methods
The parameter estimates shown in Table 1 were obtained
through a trial-and-error iterative process of nonlinear
least squares curve fitting under various, convergence ena-
bling, parameter fixations (i.e. profile searches). In the
end, the curve fits were those of Figure 2 with correspond-
ing parameter estimates in Table 1; large 95% confidence
intervals (not shown) allowed rounding of the parameter
estimates to somewhat arbitrary choices. Non-linear least
squares parameter estimations were performed using the
optimization method of Nelder and Mead [13] and the
statistical computing environment R [14]. All parameters
were estimated as ec  to assure positive values. For
additional details, R scripts are available with the data as
supplementary material [15].
List of abbreviations
RNR = ribonucleotide reductase; dNTP = deoxynucleoside
tripshospate; dNDP = deoxynucleoside dipshospate; a =
activation; i = inactivation; s = specificity; h = hexameriza-
tion;  t  = tetramerization; d  = dimerization; CI =
confidence interval; SBML = Systems Biology Markup
Language.
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